#365: Medical Device Reporting: The Do's and Don'ts

Global Medical Device Podcast · 7 May 2024 · 40m · Episode 365

What this episode covers

Lisa Van Ryn, a medical device guru at Greenlight Guru, explains the FDA’s Medical Device Reporting (MDR) requirements, detailing how manufacturers must evaluate complaints to determine reportability under 21 CFR Part 803. She outlines a decision tree for identifying serious injuries and device malfunctions, emphasizing that the reporting clock starts when any company employee becomes aware of an event, not just quality staff. Van Ryn highlights the distinction between 5-day and 30-day reports based on the need for remedial action to prevent public health risks, and warns against the pitfalls of ignoring customer feedback for trend analysis.

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 29m

    015 - "Would You Use it on a Family Member?" with Monir El Azzouzi

    Monir El Azzouzi of Easy Medical Device explains the transition from the EU Medical Device Directive (MDD) to the Medical Device Regulation (MDR), highlighting the shift from self-certification to notified body oversight and the impact on private labeling. He details the structural differences between US FDA pathways (510k, PMA) and EU classification rules, noting that MDR requires full technical files for brand owners rather than just distributors. El Azzouzi also discusses the role of notified bodies, the conflict of interest preventing them from offering pre-submission guidance, and the importance of the 'would you use it on your family?' mantra in quality assurance.

  • Let's Combinate · 47m

    068 - Benefit/Risk Ratios, PRRC, and Mythical Medical with David Rutledge

    David Rutledge, CEO of Global Strategic Solutions and author of 'Mythical Medical', discusses the critical importance of demonstrating product benefit in medical device development, arguing that the industry has historically focused too heavily on risk. He details the role of the Person Responsible for Regulatory Compliance (PRRC) under EU MDR, emphasizing the need for cross-functional teams to define and validate benefits through diverse data sources. Rutledge also shares insights from his book, using narrative characters to illustrate common regulatory pitfalls, audit preparation strategies, and the emotional weight of ensuring patient safety in combination products.

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

  • Let's Combinate · 34m

    117 - Post Market Surveillance, Safety Reporting, Databases, Platforms Health Hazards Assessments and Product Responsibilities with Khaudeja Bano

    Khaudeja Bano, VP of Quality for Combination Products at Amgen, discusses post-market surveillance and safety reporting requirements for combination products under 21 CFR Part 4B. She explains the distinction between primary mode of action reporting (e.g., FAERS for drugs) and device-specific reporting, the importance of cross-functional teams in risk management, and strategies for handling platform-based products. Bano also details the complexities of international reporting timelines, such as 24-hour requirements in China, and the role of Health Hazard Evaluations in determining corrective actions.

  • Let's Combinate · 43m

    120 - EU MDR R&R: What's the difference between Legal Manufacturer, Authorized Rep, PRRC, Importer and Distributor? with Founder of Easy Medical Device, Monir El Azzouzi

    Monir El Azzouzi, founder of Easy Medical Device, explains the distinct roles of legal manufacturer, authorized representative, importer, and distributor under the EU Medical Device Regulation (MDR). He details how these economic operators share liability for product compliance, with authorized representatives and importers performing specific verification checks on technical documentation and labeling before products enter the market. El Azzouzi emphasizes that while distributors handle physical logistics, importers and authorized reps are responsible for regulatory clearance, including maintaining traceability through UDI and EUDAMED database registrations. The conversation highlights the critical importance of clear mandates, quality agreements, and the legal obligation for authorized representatives to terminate contracts with non-compliant manufacturers to avoid personal liability.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.